Title : THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.

Pub. Date : 2019 Apr

PMID : 30262570

1 Functional Relationships(s)
Compound Name
Protein Name
1 The 5-year event-free survival was 80.9+-2.2% among patients assigned to antithrombin compared to 85.9+-2.0% in the unfractionated heparin group (P=0.06), and 86.2+-2.0% in the enoxaparin group (P=0.10). Enoxaparin serpin family C member 1 Homo sapiens